Summary
39 / 100 · Bulios Score
What speaks for it
- The price moves less than the market (beta 0.52).
What to watch
- The company made a loss over the last 12 months.
- Revenue fell by 9.3% a year over the last 3 years.
- Operating profit covers the interest on its debt only 1.5 times.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (BRL)
Diluted EPS (BRL)
- Analyst estimate
Revenue fell by 10.0% a year over 5 years. Over the last 3 years it fell by 9.3% a year. For the next fiscal year analysts expect revenue to fall by 0.8%.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of R$ 2.66B.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detail